Switzer TV

 

The year is winding down, but markets aren't. This week we put some of the market’s biggest names under the microscope. Fairmont Equities’ Michael Gable joins Paul Rickard to break down the technical and fundamental signals across Aussie blue chips and resource giants — including Rio, South32, CSL, Pro Medicus, and more.

Then Peter Switzer is joined by Morgans’ Chief Economist Michael Knox, who lays out a bold prediction for interest rates in 2026 — and why electricity supply, not demand, could be the biggest inflation driver next year.

Subscribe so you don’t miss future episodes.

Switzer Investing TV (08/12/25): Superstar stocks under the microscope | Morgans chief economist predicts 2026 market

The year is winding down, but markets aren't. This week we put some of the market’s biggest names under the microscope.

More videos

We pressure-test: ALU, NXL, UWL, AR9, SUN & Z1P

Peter Switzer is joined by Burman Invest's Julia Lee, Zip Co's Peter Gray, Shaw and Partners' Adam Dawes and Switzer's Paul Rickard.

Series:
The consequences of having a fatty liver

1 in 4 adults in the world have a fatty liver. Dr Ross Walker explains some of the alarming consequences of having a fatty liver and the best way to avoid these related issues.

Series:
Top income stocks + 12 tech stocks you have to own! Why Westpac is a screaming buy?!

Blackmore Capital's Marcus Bogdan, Morgans' Raymond Chan and Century 21's Charles Tarbey join the show.

Series:
Mad about Money

Tune in to hear Peter Switzer and Paul Rickard discuss the latest money news and how it affects you.

Series:
Dan Brady from Redcape (ASX:RDC)

Dan Brady, the CEO of hotel group Redcape, joins Peter Switzer.

Series:
Do the charts say buy: EML, IVC, Z1P, GXY + Julia’s latest buy & Jun Bei’s 5 long term holds

Joining Peter Switzer this week: Burman Invest's Julia Lee, Fairmont Equities' Michael Gable, Tribeca's Jun Bei Liu and Switzer's Paul Rickard.

Series:
Are Covid vaccines really causing blood clotting?

Dr Ross Walker puts concerns about blood clotting from the coronavirus vaccine into perspective.

Series:
Rudi’s red hot ASX stocks: CSL, IRE, HUB + CEO of EML – why is it up 12%?

On this episode: FNArena's Rudi Filapek-Vandyck, EML Payments' Tom Cregan, Msquared Capital's Paul Myliotis and Coolabah Capital's Ying Yi Ann Cheng.

Series:
Mad about Money Live

Join Peter Switzer and Paul Rickard for their weekly take on the latest money news.

Series:
Tantalising ASX tech stocks: OPY, FZ0 & More!

On this episode: Julia Lee from Burman Invest, Adam Dawes from Shaw and Partners, Rob Edgley from SelfWealth and Paul Rickard.

Series:
Can alcohol be good for you?

Dr Ross Walker believes there is a lot of misinformation around alcohol and gives you the reasons why he doesn’t necessarily agree with an Australian study on alcohol consumption.

Series:
4 stocks the experts say have BIG UPSIDE: RWC, ELO, A2M & MP1

On this week's show: Switzer's Paul Rickard, Rex's John Sharp, CoreLogic's Tim Lawless and Coolabah Capital's Ying Yi Ann Cheng.

Series:
1 32 33 34 35 36 51

Fill in the form below to subscribe to Switzer Daily and get our latest articles, videos and podcasts sent straight to your inbox

Get the latest financial, business, and political expert commentary delivered to your inbox.

When you sign up, we will never give away or sell or barter or trade your email address.

And you can unsubscribe at any time!
Subscribe
© 2006-2021 Switzer. All Rights Reserved. Australian Financial Services Licence Number 286531. 
shopping-cartphoneenvelopedollargraduation-cap linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram